PortfoliosLab logoPortfoliosLab logo
iRhythm Technologies, Inc. (IRTC)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US4500561067
CUSIP
450056106
IPO Date
Oct 20, 2016

Highlights

Market Cap
$3.93B
Enterprise Value
$4.45B
EPS (TTM)
-$1.37
Total Revenue (TTM)
$747.14M
Gross Profit (TTM)
$527.25M
EBITDA (TTM)
-$21.66M
Year Range
$92.52 - $212.00
Target Price
$217.91
ROA (TTM)
-4.37%
ROE (TTM)
-29.17%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


iRhythm Technologies, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in iRhythm Technologies, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

iRhythm Technologies, Inc. (IRTC) has returned -33.49% so far this year and 12.74% over the past 12 months.


iRhythm Technologies, Inc.

1D
3.34%
1M
-11.76%
YTD
-33.49%
6M
-31.38%
1Y
12.74%
3Y*
-1.64%
5Y*
-2.97%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Oct 20, 2016, IRTC's average daily return is +0.14%, while the average monthly return is +2.63%. At this rate, your investment would double in approximately 2.2 years.

Historically, 53% of months were positive and 47% were negative. The best month was Aug 2020 with a return of +76.9%, while the worst month was Apr 2021 at -43.9%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 9 months.

On a daily basis, IRTC closed higher 51% of trading days. The best single day was Nov 3, 2021 with a return of +59.0%, while the worst single day was Apr 12, 2021 at -39.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-12.92%-13.44%-11.76%-33.49%
202520.72%1.20%-4.97%2.11%31.44%9.58%-8.95%21.26%1.18%8.90%0.38%-5.62%96.78%
202411.90%-0.94%-2.23%-5.53%-19.50%22.03%-19.87%-17.82%4.74%-2.42%20.05%3.69%-15.76%
20234.94%19.72%5.40%5.94%-13.04%-8.71%0.71%-1.61%-8.81%-16.70%8.61%25.52%14.27%
20226.07%3.56%21.81%-21.65%14.17%-23.30%43.14%-4.64%-15.04%1.76%-14.46%-14.10%-20.41%
2021-29.00%-4.47%-13.70%-43.93%-3.08%-12.07%-22.95%-6.49%22.51%19.77%50.56%11.45%-50.39%

Benchmark Metrics

iRhythm Technologies, Inc. has an annualized alpha of 21.02%, beta of 1.17, and R² of 0.12 versus S&P 500 Index. Calculated based on daily prices since October 21, 2016.

  • This stock captured 111.99% of S&P 500 Index gains but only 92.41% of its losses — a favorable profile for investors.
  • R² of 0.12 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
21.02%
Beta
1.17
0.12
Upside Capture
111.99%
Downside Capture
92.41%

Return for Risk

Risk / Return Rank

IRTC ranks 49 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


IRTC Risk / Return Rank: 4949
Overall Rank
IRTC Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
IRTC Sortino Ratio Rank: 4949
Sortino Ratio Rank
IRTC Omega Ratio Rank: 4747
Omega Ratio Rank
IRTC Calmar Ratio Rank: 4848
Calmar Ratio Rank
IRTC Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for iRhythm Technologies, Inc. (IRTC) and compare them to a chosen benchmark (S&P 500 Index).


IRTCBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.28

0.90

-0.62

Sortino ratio

Return per unit of downside risk

0.81

1.39

-0.58

Omega ratio

Gain probability vs. loss probability

1.10

1.21

-0.11

Calmar ratio

Return relative to maximum drawdown

0.31

1.40

-1.09

Martin ratio

Return relative to average drawdown

0.88

6.61

-5.72

Explore IRTC risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


iRhythm Technologies, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the iRhythm Technologies, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the iRhythm Technologies, Inc. was 84.39%, occurring on Aug 19, 2021. The portfolio has not yet recovered.

The current iRhythm Technologies, Inc. drawdown is 56.04%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-84.39%Jan 21, 2021147Aug 19, 2021
-43.01%Mar 6, 20209Mar 18, 202029Apr 29, 202038
-37.92%Sep 17, 201869Dec 24, 201845Mar 1, 2019114
-37.33%Mar 4, 2019205Dec 20, 201949Mar 4, 2020254
-30.77%Nov 16, 202014Dec 4, 202030Jan 20, 202144

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of iRhythm Technologies, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how iRhythm Technologies, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for IRTC relative to other companies in the Medical Devices industry. Currently, IRTC has a P/S ratio of 5.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for IRTC in comparison with other companies in the Medical Devices industry. Currently, IRTC has a P/B value of 25.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items